Fluence Partners with Psyence Biomed and iNGEN ū CRO to Train Research Therapists for Phase IIb Psilocybin Trial
New collaboration on psilocybin-assisted psychotherapy trial for Adjustment Disorder in cancer patients NEW YORK, April 8, 2024 /PRNewswire-PRWeb/ -- Fluence, a global leader in professional education and training for psychedelic therapy research, announces an exciting partnership with...
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news
More News: Cancer | Cancer & Oncology | Education | Partnerships | Pharmaceuticals | Psychotherapy | Training | Universities & Medical Training